Evaluating the Implementation and Impact of Standard-of-care Delivered Oncology Financial Navigation (NCT07281287) | Clinical Trial Compass
RecruitingNot Applicable
Evaluating the Implementation and Impact of Standard-of-care Delivered Oncology Financial Navigation
United States40 participantsStarted 2025-02-01
Plain-language summary
The purpose of this study is to understand the implementation and impact of a pragmatically-delivered oncology financial navigation program. The main questions it aims to answer are:
1. How did oncology financial navigation implementation strategies affect implementation outcomes?
2. What is the impact of financial navigation on patient financial hardship, quality of life, and psychological distress?
3. How were implementation strategies utilized to overcome barriers to oncology financial navigation?
Researchers will examine secondary, standard-of-care collected, patient-reported data, electronic medical record data, and qualitative interview data to answer these questions.
Who can participate
Age range
18 Years
Sex
ALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion criteria
. All patients with cancer seen at the University of Alabama at Birmingham (UAB) Medical Oncology clinic
. UAB oncology financial navigators
Exclusion criteria
. Patients with cancer seen at the UAB Medical Oncology clinic
. Patients with non-missing patient-reported outcome data
. Patients who have received oncology financial navigation
. Providers (oncology financial navigators, social workers, nurse managers, oncologists) involved with the oncology financial navigation program
Questions worth asking your doctor
Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.
1Based on my diagnosis and history, is this trial worth exploring for me — or is there a standard treatment we should try first?
2What does this trial's phase tell us about how much is already known about its safety and benefit?
3What would taking part actually involve for me — visits, tests, time, and travel?
4What are the known and possible risks or side effects I should weigh, and how would they be monitored?
5If this trial isn't the right fit, what other options or trials would you suggest I look into?
Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.
Questions for the trial coordinator
The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.
1What does taking part actually involve week to week — how many visits, where, and how long does each one take?
2What costs are covered by the study, and what might I have to pay for myself, including travel, parking, or time off work?
3What happens during screening, and what happens if the study team confirms I don't meet the criteria after those tests?
4Who pays for the scans, blood work, and other tests the trial requires — the study, my insurance, or me?
5How will being in the trial affect my regular care, and will my own doctor stay informed and involved?
6Can I leave the trial at any point if I change my mind, and what would happen to my care if I do?
A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.
What they're measuring
1
Change in financial hardship
Timeframe: 6 months post-initiation of systemic therapy
2
Change in financial difficulties
Timeframe: 6 months post-initiation of systemic therapy
3
Change in quality of life
Timeframe: 6 months post-initiation of systemic therapy
4
Change in psychological distress
Timeframe: 6 months post-initiation of systemic therapy
5
Utilization of implementation strategies
Timeframe: Quarterly tracking of strategies with monthly assessment of implementation outcomes, through study completion, an average of 4 years
6
Patient, provider, and health system perspectives of oncology financial navigation implementation barriers addressed via implementation strategies
Timeframe: Annually through study completion, an average of 4 years